Lobo R

ORCID: 0009-0004-1578-9793 · 5 papers in corpus
other 2026
Efficacy of follitropin delta in potential low responders: a pooled analysis of individual patient data from five randomized controlled trials
Frontiers in endocrinology ·doi:10.3389/fendo.2026.1880515

OBJECTIVES: This study evaluated the efficacy of individualized follitropin delta dosing in patients with potential low response, defined by anti-Müllerian hormone (AMH) level <9 pmol/L, undergoing ovarian stimulation for assisted reproduct…

meta-analysis 2025
One-year cumulative live birth rate associated with the number of oocytes in ovarian stimulation with follitropin delta: a pooled analysis of four randomized controlled trials
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deaf111

STUDY QUESTION: What number of oocytes retrieved is associated with the highest cumulative live birth rates (CLBRs) in the fresh and subsequent frozen cycles following ovarian stimulation with follitropin delta? SUMMARY ANSWER: The CLBR in…

rct 2025
Ovarian stimulation with follitropin delta for in vitro fertilization: a multicentre, randomized, assessor-blind comparison with follitropin alfa using conventional dosing regimens (ADAPT-1 trial)
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deaf119

STUDY QUESTION: How do ovarian responses using conventional dosing for follitropin delta 15 µg/day compare with follitropin alfa 225 IU/day in women undergoing ovarian stimulation? SUMMARY ANSWER: The ADAPT-1 trial demonstrates similar ova…

rct 2024
BEYOND: a randomized controlled trial comparing efficacy and safety of individualized follitropin delta dosing in a GnRH agonist versus antagonist protocol during the first ovarian stimulation cycle
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deae092

STUDY QUESTION: How does a gonadotrophin-releasing hormone (GnRH) agonist versus a GnRH antagonist protocol affect ovarian response when using an individualized fixed daily dose of follitropin delta for ovarian stimulation? SUMMARY ANSWER:…

review 2012
Best practices of ASRM and ESHRE: a journey through reproductive medicine
Human Reproduction ·doi:10.1093/humrep/des338

BACKGROUND: The American Society for Reproductive Medicine (ASRM) and the European Society of Human Reproduction and Embryology (ESHRE) are the two largest societies in the world whose members comprise the major experts and professionals wo…